1. Home
  2. OLMA vs SGML Comparison

OLMA vs SGML Comparison

Compare OLMA & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SGML
  • Stock Information
  • Founded
  • OLMA 2006
  • SGML 2011
  • Country
  • OLMA United States
  • SGML Brazil
  • Employees
  • OLMA N/A
  • SGML N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SGML Industrial Machinery/Components
  • Sector
  • OLMA Health Care
  • SGML Industrials
  • Exchange
  • OLMA Nasdaq
  • SGML Nasdaq
  • Market Cap
  • OLMA 725.5M
  • SGML 743.4M
  • IPO Year
  • OLMA 2020
  • SGML N/A
  • Fundamental
  • Price
  • OLMA $8.72
  • SGML $5.57
  • Analyst Decision
  • OLMA Strong Buy
  • SGML Strong Buy
  • Analyst Count
  • OLMA 6
  • SGML 2
  • Target Price
  • OLMA $23.00
  • SGML $13.00
  • AVG Volume (30 Days)
  • OLMA 1.5M
  • SGML 4.3M
  • Earning Date
  • OLMA 11-07-2025
  • SGML 11-14-2025
  • Dividend Yield
  • OLMA N/A
  • SGML N/A
  • EPS Growth
  • OLMA N/A
  • SGML N/A
  • EPS
  • OLMA N/A
  • SGML N/A
  • Revenue
  • OLMA N/A
  • SGML $134,494,014.00
  • Revenue This Year
  • OLMA N/A
  • SGML $40.75
  • Revenue Next Year
  • OLMA N/A
  • SGML $63.82
  • P/E Ratio
  • OLMA N/A
  • SGML N/A
  • Revenue Growth
  • OLMA N/A
  • SGML N/A
  • 52 Week Low
  • OLMA $2.86
  • SGML $4.25
  • 52 Week High
  • OLMA $13.51
  • SGML $15.56
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 47.84
  • SGML 41.36
  • Support Level
  • OLMA $7.80
  • SGML $5.75
  • Resistance Level
  • OLMA $8.48
  • SGML $6.46
  • Average True Range (ATR)
  • OLMA 0.76
  • SGML 0.64
  • MACD
  • OLMA -0.31
  • SGML -0.15
  • Stochastic Oscillator
  • OLMA 44.15
  • SGML 6.06

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SGML Sigma Lithium Corporation

Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds a 100% interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil.

Share on Social Networks: